Other formats:
BibTeX
LaTeX
RIS
@article{1410057,
author = {Marques, Sérgio Manuel and Daniel, Lukáš and Buryška, Tomáš and Prokop, Zbyněk and Brezovský, Jan and Damborský, Jiří},
article_location = {Hoboken, USA},
article_number = {5},
doi = {http://dx.doi.org/10.1002/med.21430},
keywords = {drug design; protein tunnels; protein gates; drug binding; selectivity; specificity},
language = {eng},
issn = {0198-6325},
journal = {MEDICINAL RESEARCH REVIEWS},
title = {Enzyme Tunnels and Gates As Relevant Targets in Drug Design},
url = {https://loschmidt.chemi.muni.cz/peg/wp-content/uploads/2016/12/Marques_16res_rev.pdf},
volume = {37},
year = {2017}
}
TY - JOUR
ID - 1410057
AU - Marques, Sérgio Manuel - Daniel, Lukáš - Buryška, Tomáš - Prokop, Zbyněk - Brezovský, Jan - Damborský, Jiří
PY - 2017
TI - Enzyme Tunnels and Gates As Relevant Targets in Drug Design
JF - MEDICINAL RESEARCH REVIEWS
VL - 37
IS - 5
SP - 1095-1139
EP - 1095-1139
PB - WILEY
SN - 01986325
KW - drug design
KW - protein tunnels
KW - protein gates
KW - drug binding
KW - selectivity
KW - specificity
UR - https://loschmidt.chemi.muni.cz/peg/wp-content/uploads/2016/12/Marques_16res_rev.pdf
N2 - Many enzymes contain tunnels and gates that are essential to their function. Gates reversibly switch between open and closed conformations and thereby control the traffic of small molecules-substrates, products, ions, and solvent molecules-into and out of the enzyme's structure via molecular tunnels. Many transient tunnels and gates undoubtedly remain to be identified, and their functional roles and utility as potential drug targets have received comparatively little attention. Here, we describe a set of general concepts relating to the structural properties, function, and classification of these interesting structural features. In addition, we highlight the potential of enzyme tunnels and gates as targets for the binding of small molecules. The different types of binding that are possible and the potential pharmacological benefits of such targeting are discussed. Twelve examples of ligands bound to the tunnels and/or gates of clinically relevant enzymes are used to illustrate the different binding modes and to explain some new strategies for drug design. Such strategies could potentially help to overcome some of the problems facing medicinal chemists and lead to the discovery of more effective drugs.
ER -
MARQUES, Sérgio Manuel, Lukáš DANIEL, Tomáš BURYŠKA, Zbyněk PROKOP, Jan BREZOVSKÝ and Jiří DAMBORSKÝ. Enzyme Tunnels and Gates As Relevant Targets in Drug Design. \textit{MEDICINAL RESEARCH REVIEWS}. Hoboken, USA: WILEY, 2017, vol.~37, No~5, p.~1095-1139. ISSN~0198-6325. Available from: https://dx.doi.org/10.1002/med.21430.
|
